Miracll(SZ:300848)2022-10-24 16:00Revenue and Profit - Revenue for Q3 2022 was CNY 372,842,981.84, a decrease of 1.20% year-on-year, while year-to-date revenue reached CNY 1,166,240,366.50, an increase of 29.10%[3] - Net profit attributable to shareholders for Q3 2022 was CNY 25,384,031.00, down 16.83% year-on-year, with year-to-date net profit at CNY 80,949,669.11, an increase of 6.39%[3] - Basic earnings per share for Q3 2022 was CNY 0.13, a decrease of 13.33% compared to the same period last year, while year-to-date basic earnings per share was CNY 0.40, an increase of 5.26%[3] - The net profit for the current period is CNY 81,260,747.01, an increase from CNY 76,082,889.06 in the previous period, representing a growth of approximately 4.5%[21] - The total profit for the current period is CNY 96,120,757.97, compared to CNY 89,643,747.63 in the previous period, reflecting an increase of approximately 7.3%[21] - The company’s operating profit for the current period is CNY 96,336,650.78, an increase from CNY 89,539,421.13 in the previous period, representing a growth of about 7.9%[21] Assets and Liabilities - Total assets at the end of Q3 2022 were CNY 1,709,914,344.48, reflecting a 1.30% increase from the end of the previous year[4] - Total assets as of September 30, 2022, were RMB 1,709,914,344.48, up from RMB 1,687,997,248.82 at the beginning of the year, marking a growth of 1.3%[17] - Total liabilities decreased to RMB 690,104,011.24 from RMB 723,979,662.59, a reduction of 4.7%[16] - Shareholders' equity attributable to the parent company increased by 6.11% year-on-year, reaching CNY 943,122,226.59 at the end of Q3 2022[4] - Shareholders' equity increased to RMB 1,019,810,333.24 from RMB 964,017,586.23, reflecting a growth of 5.8%[17] Cash Flow - The net cash flow from operating activities for the first nine months of 2022 was CNY -30,346,027.66, a significant decrease of 172.95% compared to CNY 41,596,669.62 in the same period of 2021[9] - The cash flow from operating activities showed a net outflow of CNY -30,346,027.66, a decline from a net inflow of CNY 41,596,669.62 in the previous period[24] - The cash and cash equivalents at the end of the period totaled CNY 398,977,706.73, a decrease from CNY 423,241,990.97 in the previous period[25] - Cash and cash equivalents as of September 30, 2022, were RMB 415,268,706.73, compared to RMB 371,132,753.41 at the beginning of the year, reflecting a growth of 11.9%[14] - The cash flow from investing activities generated a net inflow of CNY 8,793,343.13, down from CNY 81,976,505.47 in the previous period[24] Research and Development - Research and development expenses for the first nine months of 2022 were CNY 51,892,623.20, a 42.71% increase compared to CNY 36,361,070.40 in the same period of 2021[9] - Research and development expenses increased to RMB 51,892,623.20, representing a rise of 42.8% from RMB 36,361,070.40 in the previous period[18] Inventory and Receivables - The company reported a significant increase in inventory, with a decrease of 30.03% year-on-year, attributed to a reduction in stock quantity[8] - Inventory decreased to RMB 239,418,046.60 from RMB 342,176,648.39, showing a decline of 30.0%[15] - Accounts receivable increased to RMB 113,050,753.30 from RMB 41,709,278.61, indicating a significant rise of 171.5%[15] Financial Expenses - The company’s financial expenses showed a 79.90% increase due to growth in foreign exchange gains[9]